Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy

Journal of Hypertension

Volumn 28, Issue 8, 2010, Pages 1638-1645

  Rubattu, Speranza ^a,b   Barbato, Antonio ^c   Marchitti, Simona ^b   Iacone, Roberto ^c   Di Castro, Sara ^b   Evangelista, Anna ^b   Stanzione, Rosita ^b   Ippolito, Renato ^c   Sciarretta, Sebastiano ^a   Palmieri, Luigi ^d   Volpe, Massimo ^a,b   Strazzullo, Pasquale ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

age; blood pressure; cardiovascular risk; natriuresis; natriuretic peptides; renal function

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CREATININE; N TERMINAL PROATRIAL NATRIURETIC PEPTIDE; SODIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; HEALTH SURVEY; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HUMAN; ITALY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PULSE PRESSURE; RISK ASSESSMENT; SAMPLING; SODIUM URINE LEVEL; URINARY EXCRETION;

EID: 77954955135     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833a39aa     Document Type: Article

References (36)

1. Levis ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339:321-328.
2. Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; 1:179-181.
3. Burnett JC Jr, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231:1145-1147.
4. Chen HH. Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!. J Am Coll Cardiol 2007; 49:1089-1091.
5. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008; 21:733-741.
6. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663.
7. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson P, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90:254-258.
8. Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K, Eto T. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 2002; 25:887-892.
9. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89:745-751.
10. Wang TJ, Larson MG, Levy D,Benjamin EJ, Leip EP, Wilson PW, Vasan RS. The impact of obesity on plasma natriuretic peptide levels: the Framingham Heart Study. Circulation 2004; 109:594-600.
11. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 2005; 46:660-666.
12. Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, et al. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass. J Hypertens 2007; 25: 833-839.
13. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population based study. JAMA 1993; 270:354-359.
14. Galletti F, Barbato A, Versiero M, Icone R, Russo O, Barba G, et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens 2007; 25:1671-1677.
15. Wozakowska-Kapłon B, Opolski G, Herman Z, Kosior D. Natriuretic peptides in patients with atrial fibrillation. Cardiol J 2008; 15:525-529.
16. Strazzullo P, Barba G, Cappuccio FP, Siani A, Trevisan M, Farinaro E, et al. Altered renal sodium handling in men with abdominal adiposity. A link to hypertension. J Hypertens 2001; 19:2157-2164.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
18. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47:1643-1649.
19. Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, et al. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens 2006; 24:1633-1639.
20. Steiner RW. Interpreting the fractional excretion of sodium. Am J Med 1984; 77:699-702
21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
22. Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, et al. La valutazione del rischio cardiovascolare globale assoluto: il punteggio individuale del progetto CUORE. Ann Ist Super Sanità 2004; 40:1-7.
23. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-753.
24. Kanda H, Kita Y,Okamura T, Kadowaki T, Yoshida Y, Nakamura Y,Ueshima H. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Human Hypertens 2005; 19:165-172.
25. Das SR, Abdullah SM, Leonard D, Drazner MH, Khera A, McGuire DK, de Lemos JA. Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study). Am J Cardiol 2008; 102:1394-1398.
26. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Natriuretic peptide precursor gene polymorphisms and risk of blood pressure progression and incident hypertension. Hypertension 2007; 50:1114-1119.
27. Rubattu S, Evangelista A, Barbato D, Barba G, Stanzione R, Icone R, et al. Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans. J Human Hypertens 2007; 21:822-824.
28. Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker-Foster C, Arnett DK. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA 2008; 299:296-307.
29. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nature Genetics 2009; 41:348-353.
30. Volpe M. Atrial natriuretic peptide and the baroreflex control of circulation. Am J Hypertens 1992; 5:488-493.
31. Luchner A, Schunkert H. Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system. Cardiovasc Res 2004; 63:443-449.
32. Maack T. The broad homeostatic role of natriuretic peptides. Arq Bras Endocrinol Metab 2006; 50:198-207.
33. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23:363-384.
34. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339:b4567.
35. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med 2002; 162:1619-1624.
36. Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An unsuspected metabolic role of atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol 2005; 25:2032-2042.